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SUMMARY
EuroRotaNet, a laboratory network, was established in order to determine the diversity of
co-circulating rotavirus strains in Europe over three or more rotavirus seasons from 2006/2007
and currently includes 16 countries. This report highlights the tremendous diversity of rotavirus
strains co-circulating in the European population during three years of surveillance since 2006/
2007 and points to the possible origins of these strains including genetic reassortment and
interspecies transmission. Furthermore, the ability of the network to identify strains circulating
with an incidence ofo1% allowed the identiﬁcation of possible emerging strains such as G8 and
G12 since the beginning of the study; analysis of recent data indicates their increased incidence.
The introduction of universal rotavirus vaccination in at least two of the participating countries,
and partial vaccine coverage in some others may provide data on diversity driven by vaccine
introduction and possible strain replacement in Europe.
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INTRODUCTION
Rotaviruses are a major cause of gastroenteritis in
children aged<5 years worldwide [1, 2] and of acute
diarrhoea in the young of many other mammalian
species (calves, piglets, lambs, rabbits, etc.). They
cause more than 600 000 deaths each year, mostly of
infants and young children in developing countries
[1], and are a signiﬁcant cause of morbidity and hos-
pitalizations in developed countries.
Rotaviruses are classiﬁed according to the sero-
logical cross-reactivity of the inner capsid protein VP6
into ﬁve groups (A–E) and two more groups (F, G)
are likely to exist. Within group A rotaviruses, there
are subgroups (I, II, I+II, non-I, non-II) charac-
terized by their reactivities with two VP6-speciﬁc
monoclonal antibodies [3]. More recently, RT–PCR
has been applied to the subgroup classiﬁcation of
human rotaviruses, and only two major subgroups
have been identiﬁed [4].
In order to characterize strains on the basis of their
surface proteins VP4 and VP7, a binary classiﬁcation
scheme distinguishing types has been established
for group A rotaviruses. The system diﬀerentiates
G-types (VP7-speciﬁc, G for glycoprotein) and P-types
(VP4-speciﬁc, P for protease-sensitive protein). To
date, 23 diﬀerent G-types and 31 P-types have been
described [5–9], indicating extensive genomic diversity
within group A rotaviruses.
Rotaviruses possess a genome of 11 segments of
dsRNA and VP4 and VP7 are coded for by diﬀerent
RNA segments (segments 4 and 7, 8 or 9 depending
on strain, respectively). As rotaviruses were found to
reassort readily in doubly infected cells in vitro and
in vivo [7, 10–12], various combinations of VP4 and
VP7 types have been observed in natural rotavirus
isolates [13–16].
The European Rotavirus Network (EuroRotaNet),
was established in January 2007 [17], and has conduc-
ted rotavirus strain surveillance in Europe for three
consecutive years. Participation in EuroRotaNet is
voluntary, and the network activities are funded be-
tween the collaborating institutes and GlaxoSmith-
Kline Biologicals (GSK) and Sanoﬁ Pasteur-MSD
(SPMSD). The participating institutes provide expert-
ise, laboratory space, equipment and supervision, and
funding for labour and consumable costs associated
with strain characterization is provided in the formof an
unrestrictedcollaborativegrant inequalpartsfromGSK
and SPMSD, and administered through the Centre for
Infections, Health Protection Agency, London, UK.
The study was undertaken in order to gather com-
prehensive information of the rotavirus types co-
circulating throughout Europe, including both urban
and rural settings, and encompassing at least three
consecutive rotavirus seasons. The aims of the study
were (i) to develop methods and algorithms for eﬀec-
tive rotavirus typing (G and P) and characterization
(including VP6 and NSP4 genotypes) and to monitor
the eﬀectiveness of current genotyping methods and
respond to changes associated with genetic drift and
shift ; (ii) to describe in detail the molecular epidemi-
ology of rotavirus infections in Europe, during con-
secutive rotavirus seasons, through genotyping of
rotavirus-positive samples collected throughout each
country; and (iii) to monitor the emergence and
spread of common and novel rotavirus strains within
Europe and develop the infrastructure that may serve
as a platform for future surveillance activities and
nested studies. These studies will be used to monitor
the eﬀectiveness of a rotavirus vaccine in the general
population, through monitoring the reduction in dis-
ease associated with common rotavirus types ; to
detect the possible vaccine-induced emergence of anti-
body escape mutants and the possible emergence in
the general population of genotypes other than those
included in the vaccine and reassortants between
vaccine and naturally circulating wild-type strains.
MATERIALS AND METHODS
Samples
Hospitals, paediatricians and general medical practi-
tioners that were willing to participate in the study
over several years were identiﬁed in each of the
participating countries in order to allow valid com-
parisons to be made between each rotavirus season
and within each member country. Faecal samples
submitted for the routine laboratory investigation
of infantile gastroenteritis and positive for group A
rotavirus antigen were collected for genotyping.
A total of 19 140 rotavirus-positive samples were
genotyped between September 2006 and August 2009
in 15 European countries (Table 1).
Rotavirus genotyping
Rotavirus strains were characterized through geno-
typing using standardized methods to identify their
G- and P-types [Manual of rotavirus detection and
characterization methods, WHO (http://www.who.int/
nuvi/rotavirus/WHO_IVB_08.17_eng.pdf); European
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rotavirus detection and characterization methods v4
(http://www.eurorota.net/docs.php)] and following
the algorithm described in Figure 1. Rotavirus sub-
groups (VP6) and NSP4 genotypes were determined
for uncommon or novel strains identiﬁed through G-
and P-typing in order to identify possible zoonotic
transmission [18, 19] (European rotavirus detection
and characterization methods v4).
Epidemiological data
Epidemiological data including age, sex, geographical
location, including postcode in some countries,
setting (hospital or community, urban or rural),
symptoms (diarrhoea, vomiting, or diarrhoea and
vomiting, or other) and date of onset and date of
sample collection were entered into a web-accessible
database and linked to the genotyping data (http://
www.eurorota.net/).
Table 1. Number of rotavirus strains in the
EuroRotaNet database per country and rotavirus
season (includes data for September to August in each
of the three season from 2006 to 2009; entries for which
date of sample collection was incomplete were
excluded)
Country
2006/
2007
2007/
2008
2008/
2009
Study
target Total
% target
achieved
Belgium 607 214 940 821 87.3
Bulgaria 338 328 299 940 965 102.7
Denmark 185 270 245 1410 700 49.7
Finland 142 266 226 1410 634 45.0
France 578 764 620 2193 1962 89.5
Germany 39 964 752 2877 1755 61.0
Greece ns ns 96 470 96 20.4
Hungary 388 586 436 1410 1410 100.0
Italy 347 1290 748 2103 2385 113.4
Lithuania 1 564 446 940 1011 107.6
The
Netherlands
16 139 838 1410 993 70.4
Romania n.s. n.s. t.b.u. 470 — 0.0
Slovenia 353 631 234 1410 1218 86.4
Spain 544 662 530 2352 1736 73.8
Sweden 32 578 115 1410 725 51.4
UK 844 910 975 2115 2729 129.0
Total 3807 8559 6774 23 860 19 140 80.2
n.s., No sampling ; t.b.u., to be uploaded.
Belgium, Bulgaria and Lithuania joined the network in
2008, Greece and Romania in 2009. Only data uploaded up
to 31 December 2009 is included in the analysis.
Faecal samples Epidemiology:Age, sex, geographical
location, setting, date of
collectionGroup A rotavirus antigen detection
Negative Rotavirus positive
Nucleic acid extraction
Reverse transcription
G-typing PCR P-typing PCR
Common CommonUncommon Uncommon
VP7, VP4,
sequencing
Results to database
Fig. 1. Algorithm describing the testing and reporting of
rotavirus-positive samples.
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Fig. 2. Temporal distribution of rotavirus infections in
the EuroRotaNet database in three consecutive seasons,
2006/2007, 2007/2008 and 2008/2009. (a) Numbers of
strains each month in three consecutive seasons. (b) Percent
of the total rotavirus strains in a season each month
showing the moving-average trend analysis.
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RESULTS
Temporal distribution
Rotavirus infections peak in the winter months
in temperate climates, and the analysis of the
data in EuroRotaNet reﬂects this seasonality. The
peak of rotavirus infections in Europe occurred
in March in all three seasons between 2006 and
2009 (Fig. 2). The moving-average trend analysis in-
dicated that rotavirus infections peaked in April in
Table 2. Possible origins of rotavirus strains circulating within Europe. Common and reassortant human rotavirus
strains, zoonotic strains and animal-human hybrid rotavirus strains are identiﬁed
2006/2007 2007/2008 2008/2009 Total
No. % No. % No. % No. %
Common human rotavirus genotypes
G1P[8] 1637 43.00 4532 52.95 3101 45.78 9270 48.43
G2P[4] 584 15.34 747 8.73 597 8.81 1928 10.07
G3P[8] 113 2.97 324 3.79 381 5.62 818 4.27
G4P[8] 282 7.41 1282 14.98 1318 19.46 2882 15.06
G9P[8] 768 20.17 900 10.52 544 8.03 2212 11.56
Reassortment among common human rotavirus genotypes
G1P[4] 11 0.29 30 0.35 15 0.22 56 0.29
G2P[8] 21 0.55 46 0.54 23 0.34 90 0.47
G3P[4] 1 0.03 1 0.01 5 0.07 7 0.04
G4P[4] 1 0.03 6 0.07 17 0.25 24 0.13
G9P[4] 4 0.11 16 0.19 16 0.24 36 0.19
Potential zoonotic rotavirus genotypes
G3P[3] 1 0.03 0 0.00 0 0.00 1 0.01
G3P[6] 0 0.00 0 0.00 9 0.13 9 0.05
G3P[9] 0 0.00 2 0.02 3 0.04 5 0.03
G6P[9] 4 0.11 3 0.04 1 0.01 8 0.04
G6P[14] 1 0.03 3 0.04 0 0.00 4 0.02
G8P[6] 4 0.11 1 0.01 1 0.01 6 0.03
G8P[14] 0 0.00 1 0.01 2 0.01 3 0.01
G9P[6] 5 0.13 0 0.00 4 0.06 9 0.05
G9P[9] 2 0.05 3 0.04 1 0.01 6 0.03
G9P[10] 0 0.00 1 0.01 1 0.01 2 0.01
G10P[14] 5 0.13 1 0.01 0 0.00 6 0.03
G12P[9] 0 0.00 4 0.05 4 0.06 8 0.04
Possible human-animal hybrid rotavirus genotypes
G1P[6] 0 0.00 0 0.00 4 0.06 4 0.02
G2P[6] 5 0.13 17 0.20 2 0.03 24 0.13
G2P[9] 1 0.03 1 0.01 0 0.00 2 0.01
G2P[10] 1 0.03 0 0.00 0 0.00 1 0.01
G4P[6] 5 0.13 0 0.00 3 0.04 8 0.04
G4P[9] 0 0.00 1 0.01 1 0.01 2 0.01
G4P[10] 0 0.00 0 0.00 1 0.01 1 0.01
G6P[4] 0 0.00 1 0.01 0 0.00 1 0.01
G6P[8] 0 0.00 2 0.02 0 0.00 2 0.01
G6P[11] 1 0.03 0 0.00 0 0.00 1 0.01
G8P[4] 0 0.00 3 0.04 63 0.93 66 0.34
G8P[8] 2 0.05 2 0.02 6 0.09 10 0.05
G10P[4] 1 0.03 2 0.02 0 0.00 3 0.02
G10P[6] 0 0.00 1 0.01 0 0.00 1 0.01
G10P[8] 0 0.00 6 0.07 15 0.22 21 0.11
G10P[10] 0 0.00 1 0.01 0 0.00 1 0.01
G12P[4] 0 0.00 0 0.00 3 0.04 3 0.02
G12P[6] 1 0.03 4 0.05 41 0.61 46 0.24
G12P[8] 21 0.55 46 0.54 52 0.77 119 0.62
Total 3482 91.46 7990 93.35 6234 92.03 17 706 92.51
4 M. Iturriza-Go´mara and others
2006/2007 and in March in 2007/2008 and 2008/2009
(Fig. 2).
Diﬀerences were observed across EuroRotaNet
participating countries in the month in which rota-
virus infections peaked. The earliest peaks of infection
were detected in Spain in 2006/2007 and 2008/2009,
in January and December, respectively, and in 2007/
2008 infection peaked in February. Late season peaks
were associated with countries in the East or North of
Europe with infection peaking in Hungary in May
2007 and in Finland in May 2008 and 2009.
Genotype distribution
Total dataset
The total number of rotavirus-positive samples in-
cluded were 19 140 for the 3 years and included 3807
in 2006/2007, 8559 in 2007/2008, and 6774 in 2008/
2009. These numbers were used as denominators for
calculating percentages. A total of 141 diﬀerent com-
binations of G- and P-types were found between 2006
and 2009 and included those with combinations either
singly or as multiple infections of G1, G2, G3, G4,
G6, G8, G9, G10, G12 and P[3], P[4], P[6], P[8], P[9],
P[10], P[11], P[14] genotypes (Table 2).
Common rotavirus strains
G1P[8] rotavirus strains were predominant in all three
seasons between 2006 and 2009. Strains circulating
with a prevalence of>1% included G1P[8] (48.43%),
G4P[8] (15.06%), G9P[8] (11.56%), G2P[4] (10.07%)
and G3P[8] (4.27%) (Table 2).
Possible origins of rotavirus strains
Rotavirus strains found circulating within the
European population between 2006 and 2009 can be
stratiﬁed according to their possible origins. Human
rotavirus strains are the most prevalent, making up
89.4% of circulating strains. Strains whose derivation
may be associated with reassortment between animal
and human strains make up 1.7% and reassortants of
the common human strains make up 1.1%. Infection
with rotavirus strains of animal origin may represent
0.3% of strains found (Table 2).
Table 3 (a). Co-infections with multiple rotavirus strains (single G-type with two or more P-types)
2006/2007 2007/2008 2008/2009 Total
No. % No. % No. % No. %
G1P[4]+P[8] 10 0.26 19 0.22 22 0.32 51 0.27
G2P[4]+P[8] 6 0.16 6 0.07 12 0.18 24 0.13
G9P[4]+P[8] 6 0.16 10 0.12 8 0.12 24 0.13
G9P[6]+P[8] 1 0.03 6 0.07 2 0.03 9 0.05
G4P[4]+P[8] 1 0.03 2 0.02 3 0.04 6 0.03
G3P[4]+P[8] 3 0.08 1 0.01 1 0.01 5 0.03
G8P[4]+P[6] 0 0.00 0 0.00 5 0.07 5 0.03
G1P[6]+P[8] 1 0.03 1 0.01 1 0.01 3 0.02
G10P[4]+P[8] 0 0.00 1 0.01 1 0.01 2 0.01
G12P[4]+P[8] 0 0.00 1 0.01 1 0.01 2 0.01
G1P[8]+P[10] 0 0.00 1 0.01 1 0.01 2 0.01
G2P[4]+P[6] 1 0.03 0 0.00 1 0.01 2 0.01
G2P[6]+P[8] 2 0.05 0 0.00 0 0.00 2 0.01
G8P[6]+P[8] 0 0.00 0 0.00 2 0.03 2 0.01
G12P[8]+P[9] 0 0.00 0 0.00 1 0.01 1 0.01
G12P[9]+P[11] 0 0.00 0 0.00 1 0.01 1 0.01
G1P[4]+P[6]+P[8] 0 0.00 1 0.01 0 0.00 1 0.01
G1P[8]+P[9] 0 0.00 1 0.01 0 0.00 1 0.01
G2P[4]+P[9] 1 0.03 0 0.00 0 0.00 1 0.01
G3P[4]+P[6] 0 0.00 0 0.00 1 0.01 1 0.01
G4P[4]+P[6] 0 0.00 0 0.00 1 0.01 1 0.01
G8P[4]+P[8] 0 0.00 0 0.00 1 0.01 1 0.01
G9P[8]+P[9] 1 0.03 0 0.00 0 0.00 1 0.01
Total 33 0.87 50 0.58 65 0.96 148 0.77
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Mixed rotavirus infections
A total of 809 mixed rotavirus infections were
detected between 2006 and 2009. These could be
classiﬁed as single G-type with two or more P-types
(148, 0.8%), multiple G-types with a single P-type
(534, 2.8%) or multiple G- and P-types (127, 0.7%).
These strains are representative of those genotypes
Table 3 (b). Co-infections with multiple rotavirus strains (multiple G-types with a single P-type)
2006/2007 2007/2008 2008/2009 Total
No. % No. % No. % No. %
G1+G9P[8] 70 1.84 103 1.20 34 0.50 207 1.08
G1+G4P[8] 5 0.13 36 0.42 36 0.53 77 0.40
G1+G2P[4] 5 0.13 22 0.26 9 0.13 36 0.19
G4+G9P[8] 1 0.03 12 0.14 19 0.28 32 0.17
G3+G9P[8] 8 0.21 12 0.14 10 0.15 30 0.16
G1+G3P[8] 5 0.13 10 0.12 7 0.10 22 0.11
G1+G2P[8] 9 0.24 4 0.05 2 0.03 15 0.08
G1+G10P[8] 0 0.00 9 0.11 2 0.03 11 0.06
G1+G12P[8] 2 0.05 2 0.02 5 0.07 9 0.05
G2+G4P[8] 4 0.11 0 0.00 5 0.07 9 0.05
G1+G2+G9P[8] 8 0.21 0 0.00 0 0.00 8 0.04
G2+G4P[4] 0 0.00 3 0.04 5 0.07 8 0.04
G2+G9P[4] 4 0.11 2 0.02 2 0.03 8 0.04
G3+G8P[8] 0 0.00 0 0.00 6 0.09 6 0.03
G9+G12P[8] 0 0.00 1 0.01 4 0.06 5 0.03
G2+G9P[8] 3 0.08 0 0.00 1 0.01 4 0.02
G3+G4P[8] 1 0.03 0 0.00 3 0.04 4 0.02
G1+G3+G9P[8] 3 0.08 0 0.00 0 0.00 3 0.02
G1+G9P[4] 2 0.05 1 0.01 0 0.00 3 0.02
G4+G12P[8] 0 0.00 2 0.02 1 0.01 3 0.02
G1+G4+G9P[8] 1 0.03 1 0.01 0 0.00 2 0.01
G1+G9P[6] 1 0.03 0 0.00 1 0.01 2 0.01
G2+G12P[4] 0 0.00 0 0.00 2 0.03 2 0.01
G2+G3P[4] 0 0.00 0 0.00 2 0.03 2 0.01
G3+G9+G12P[8] 0 0.00 2 0.02 0 0.00 2 0.01
G4+G8P[4] 0 0.00 0 0.00 2 0.03 2 0.01
G9+G10P[8] 0 0.00 0 0.00 2 0.03 2 0.01
G1+G12P[4] 0 0.00 0 0.00 1 0.01 1 0.01
G1+G12P[6] 1 0.03 0 0.00 0 0.00 1 0.01
G1+G2+G3P[8] 1 0.03 0 0.00 0 0.00 1 0.01
G1+G2+G4P[8] 0 0.00 0 0.00 1 0.01 1 0.01
G1+G2+G9P[4] 1 0.03 0 0.00 0 0.00 1 0.01
G1+G6P[9] 0 0.00 1 0.01 0 0.00 1 0.01
G1+G8+G12P[8] 0 0.00 0 0.00 1 0.01 1 0.01
G1+G8P[4] 0 0.00 0 0.00 1 0.01 1 0.01
G1+G8P[8] 0 0.00 0 0.00 1 0.01 1 0.01
G10+G12P[6] 0 0.00 0 0.00 1 0.01 1 0.01
G2+G10P[4] 0 0.00 1 0.01 0 0.00 1 0.01
G2+G9P[6] 0 0.00 1 0.01 0 0.00 1 0.01
G3+G10P[8] 0 0.00 1 0.01 0 0.00 1 0.01
G3+G8P[8] 0 0.00 1 0.01 0 0.00 1 0.01
G3+G9P[4] 0 0.00 1 0.01 0 0.00 1 0.01
G3+G9P[6] 0 0.00 1 0.01 0 0.00 1 0.01
G3+G9P[9] 1 0.03 0 0.00 0 0.00 1 0.01
G4+G10P[8] 0 0.00 0 0.00 1 0.01 1 0.01
G8+G12P[4] 0 0.00 0 0.00 1 0.01 1 0.01
G9+G3P[6] 0 0.00 1 0.01 0 0.00 1 0.01
Total 136 3.57 230 2.69 168 2.48 534 2.79
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seen in single infections and include mixtures of
human and of animal rotavirus strains (Table 3a–c).
Partially typed rotavirus strains
A total of 625 strains were partially typed, in 330
(1.72%) and 295 (1.54%) strains, only the P-type or
G-type, respectively, was obtained (Table 4).
Emerging rotavirus strains
Rotavirus strains emerging in Europe between 2006
and 2009 included G12 and G8 strains (Table 5).
These genotypes were found circulating in each of the
three seasons and both G12 (x2=22.83, P<0.0001)
and G8 (x2=69.66, P<0.0001) showed signiﬁcant
increases in the third season.
Changing molecular epidemiology
G1P[8] strains were most prevalent in the 2007/2008
season with the exception of Lithuania where only
5.5% of strains were of this genotype. Over the three
seasons, and in the majority of countries, the number
of G1P[8] strains rose in the second season and fell
in the third. The highest incidences of infection
with G2P[4] strains in any season were in Belgium,
Bulgaria and Greece where this genotype was found
in >30% of the strains. In season 1, G2P[4] was
the most prevalent strain in Bulgaria and in seasons
1 and 2 in Belgium. In the majority of countries, this
genotype accounted for <20% of strains in any
season. G3P[8] accounted for <20% of strains in
all countries in any season. This strain was not found
in the ﬁrst season in Bulgaria, Italy or Hungary, in
the second in Slovenia and in the third in Bulgaria
Table 3 (c). Co-infections with multiple rotavirus strains (multiple G- and P-types)
2006/2007 2007/2008 2008/2009 Total
No. % No. % No. % No. %
G1+G2P[4]+P[8] 14 0.37 18 0.21 10 0.15 42 0.22
G2+G9P[4]+P[8] 7 0.18 9 0.11 6 0.09 22 0.11
G2+G4P[4]+P[8] 0 0.00 2 0.02 6 0.09 8 0.04
G1+G2+G9P[4]+P[8] 5 0.13 1 0.01 1 0.01 7 0.04
G1+G9P[4]+P[8] 3 0.08 3 0.04 1 0.01 7 0.04
G2+G3P[4]+P[8] 2 0.05 0 0.00 4 0.06 6 0.03
G1+G4P[4]+P[8] 0 0.00 0 0.00 5 0.07 5 0.03
G1+G9P[6]+P[8] 3 0.08 0 0.00 0 0.00 3 0.02
G4+G9P[4]+P[8] 0 0.00 0 0.00 3 0.04 3 0.02
G1+G2P[4]+P[6] 0 0.00 1 0.01 1 0.01 2 0.01
G1+G3P[4]+P[8] 0 0.00 1 0.01 1 0.01 2 0.01
G2+G12P[4]+P[8] 1 0.03 1 0.01 0 0.00 2 0.01
G8+G12P[6]+P[8] 0 0.00 0 0.00 2 0.03 2 0.01
G1+G2+G12P[4]+P[8] 0 0.00 0 0.00 1 0.01 1 0.01
G1+G2+G3P[4]+P[8] 1 0.03 0 0.00 0 0.00 1 0.01
G1+G2+G4P[4]+P[8] 0 0.00 0 0.00 1 0.01 1 0.01
G1+G2+G4P[8]+P[10] 0 0.00 0 0.00 1 0.01 1 0.01
G1+G3P[6]+P[8] 0 0.00 1 0.01 0 0.00 1 0.01
G1+G9P[8]+P[9] 0 0.00 0 0.00 1 0.01 1 0.01
G2+G12P[6]+P[8] 0 0.00 0 0.00 1 0.01 1 0.01
G2+G4P[6]+P[8] 0 0.00 0 0.00 1 0.01 1 0.01
G2+G9P[4]+P[6] 0 0.00 0 0.00 1 0.01 1 0.01
G3+G4+G9P[8]+P[9] 0 0.00 1 0.01 0 0.00 1 0.01
G3+G4P[4]+P[8] 0 0.00 1 0.01 0 0.00 1 0.01
G3+G9P[4]+P[8] 1 0.03 0 0.00 0 0.00 1 0.01
G4+G12P[4]+P[8] 0 0.00 0 0.00 1 0.01 1 0.01
G8+G12P[4]+P[6] 0 0.00 0 0.00 1 0.01 1 0.01
G9+G12P[4]+P[8] 0 0.00 1 0.01 0 0.00 1 0.01
G9+G12P[8]+P[9] 1 0.03 0 0.00 0 0.00 1 0.01
Total 38 1.00 40 0.47 49 0.72 127 0.66
Rotavirus genotypes co-circulating in Europe 7
and Greece. The prevalence of G4P[8] strains was
80% in Lithuania in 2007/2008 and >40% in
Bulgaria and Germany in 2008/2009, and was found
in all countries in the third season (2008/2009). G9P[8]
strains were the most common strain found in Spain
in the ﬁrst season (2006/2007), and the second most
common in Bulgaria, France, Italy and Finland
(Fig. 3).
G12 rotavirus strains were found to be circulating
with an incidence of>1% in nine countries including
Finland (6.8%), Denmark (3.2%), Lithuania (2.4%),
Hungary (2.3%), Greece (1.6%), The Netherlands
(1.8%), Germany (1.7%), UK (1.5%) and Bulgaria
(1.2%). With the exception of Sweden, G12 strains
were found in all other countries. G12 strains were
found in each of the three seasons in Denmark,
Hungary, UK, Bulgaria, Italy and France.
G8 strains were found in two countries in the
2006/2007 season, in seven countries in the 2007/
2008 season and in nine countries in the 2008/2009
season, with the highest incidence overall seen in
UK (2.1%). The incidence was <1% in all other
countries (Belgium, Bulgaria, Denmark, France,
Germany, Greece, Italy, Lithuania, Spain, Sweden,
The Netherlands).
Demographic data
Age distribution
Infection peaked in children aged 1–2 years, but was
seen in all age groups (Fig. 4a). Minor peaks, possibly
associated with contact with infected children or
grandchildren and waning immunity in the elderly
population could also be seen (Fig. 4b).
Distribution according to hospital or community setting
For those cases for whom the setting was provided,
62.4% of samples were collected from hospitalized
patients and 37.6% from patients in the community.
With the exception of G2P[4] strains there were no
signiﬁcant diﬀerences in the distribution of common
or emerging genotypes between hospital patients
and those in the community (Table 6a). G2P[4] was
signiﬁcantly associated (x2=22.98, P<0.0001) with
hospitalized patients and may be associated with the
periodic upsurge of G2P[4] strains, possibly associ-
ated with the selection of an antibody escape mutant.
Infection can often require hospitalization as symp-
toms may be severe in the absence of cross-reactive
antibodies associated with previous infections (seeAge
distribution section above).
Table 4. Partially typed rotavirus strains
2006/2007 2007/2008 2008/2009 Total
No. % No. % No. % No. %
G-UDP[8] 40 1.05 98 1.14 129 1.90 267 1.39
G-UDP[4] 6 0.16 8 0.09 16 0.24 30 0.16
G-UDP[4]+P[8] 3 0.08 4 0.05 4 0.06 11 0.06
G-UDP[6] 1 0.03 0 0.00 9 0.13 10 0.05
G-UDP[9] 0 0.00 0 0.00 6 0.09 6 0.03
G-UDP[10] 1 0.03 1 0.01 2 0.03 4 0.02
G-UDP[11] 0 0.00 0 0.00 1 0.01 1 0.01
G-UDP[8]+P[14] 0 0.00 0 0.00 1 0.01 1 0.01
Total 51 1.34 111 1.30 168 2.48 330 1.72
G1P-UD 24 0.63 85 0.99 40 0.59 149 0.78
G9P-UD 17 0.45 11 0.13 13 0.19 41 0.21
G2P-UD 15 0.39 13 0.15 7 0.10 35 0.18
G4P-UD 4 0.11 11 0.13 7 0.10 22 0.11
G3P-UD 3 0.08 7 0.08 10 0.15 20 0.10
G12P-UD 2 0.05 2 0.02 6 0.09 10 0.05
G10P-UD 0 0.00 3 0.04 2 0.03 5 0.03
G1+G9P-UD 0 0.00 3 0.04 1 0.01 4 0.02
G1+G4P-UD 1 0.03 1 0.01 2 0.03 4 0.02
G8P-UD 0 0.00 1 0.01 1 0.01 2 0.01
G1+G2+G9P-UD 1 0.03 0 0.00 0 0.00 1 0.01
G1+G2P-UD 0 0.00 1 0.01 0 0.00 1 0.01
G1+G3P-UD 0 0.00 0 0.00 1 0.01 1 0.01
Total 67 1.76 138 1.61 90 1.33 295 1.54
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Distribution according to rural or urban setting
For those patients for whom the setting was pro-
vided, 89.7% samples were collected from urban
populations and 10.2% from rural populations.
The percentages of the European population living
in urban and rural areas are estimated to be
73.1% and 26.9%, respectively (www.cap-lmu.de/fgz/
statistics/urban_pop.php). G1P[8] strains (x2=19.88,
P<0.0001) were found signiﬁcantly more often in
Table 5. Distribution of possible emerging strains between 2006 and 2009 as single strain infections or contributing
to multiple strain infections
2006/2007 2007/2008 2008/2009 Total
No. % No. % No. % No. %
G12P[8] 21 0.55 46 0.54 52 0.77 119 0.62
G12P[6] 1 0.03 4 0.05 41 0.61 46 0.24
G12P-UD 2 0.05 2 0.02 6 0.09 10 0.05
G1+G12P[8] 2 0.05 2 0.02 5 0.07 9 0.05
G12P[9] 0 0.00 4 0.05 4 0.06 8 0.04
G9+G12P[8] 0 0.00 1 0.01 4 0.06 5 0.03
G12P[4] 0 0.00 0 0.00 3 0.04 3 0.02
G4+G12P[8] 0 0.00 2 0.02 1 0.01 3 0.02
G3+G9+G12P[8] 0 0.00 2 0.02 0 0.00 2 0.01
G2+G12P[4] 0 0.00 0 0.00 2 0.03 2 0.01
G12P[4]+P[8] 0 0.00 1 0.01 1 0.01 2 0.01
G2+G12P[4]+P[8] 1 0.03 1 0.01 0 0.00 2 0.01
G8+G12P[6]+P[8] 0 0.00 0 0.00 2 0.03 2 0.01
G1+G12P[6] 1 0.03 0 0.00 0 0.00 1 0.01
G1+G12P[4] 0 0.00 0 0.00 1 0.01 1 0.01
G1+G8+G12P[8] 0 0.00 0 0.00 1 0.01 1 0.01
G8+G12P[4] 0 0.00 0 0.00 1 0.01 1 0.01
G12P[8]+P[9] 0 0.00 0 0.00 1 0.01 1 0.01
G12P[9]+P[11] 0 0.00 0 0.00 1 0.01 1 0.01
G1+G2+G12P[4]+P[8] 0 0.00 0 0.00 1 0.01 1 0.01
G2+G12P[6]+P[8] 0 0.00 0 0.00 1 0.01 1 0.01
G4+G12P[4]+P[8] 0 0.00 0 0.00 1 0.01 1 0.01
G9+G12P[4]+P[8] 0 0.00 1 0.01 0 0.00 1 0.01
G8+G12P[4]+P[6] 0 0.00 0 0.00 1 0.01 1 0.01
G9+G12P[8]+P[9] 1 0.03 0 0.00 0 0.00 1 0.01
G10+G12P[6] 0 0.00 0 0.00 1 0.01 1 0.01
Total G12 29 0.76 66 0.77 132 1.95 227 1.19
G8P[4] 0 0.00 3 0.04 63 0.93 66 0.34
G8P[8] 2 0.05 2 0.02 6 0.09 10 0.05
G8P[6] 4 0.11 1 0.01 1 0.01 6 0.03
G8P[14] 0 0.00 1 0.01 2 0.01 3 0.01
G3+G8P[8] 0 0.00 0 0.00 6 0.09 6 0.03
G4+G8P[4] 0 0.00 0 0.00 2 0.03 2 0.01
G1+G8+G12P[8] 0 0.00 0 0.00 1 0.01 1 0.01
G1+G8P[4] 0 0.00 0 0.00 1 0.01 1 0.01
G1+G8P[8] 0 0.00 0 0.00 1 0.01 1 0.01
G3+G8P[8] 0 0.00 1 0.01 0 0.00 1 0.01
G8+G12P[4] 0 0.00 0 0.00 1 0.01 1 0.01
G8P[4]+P[6] 0 0.00 0 0.00 5 0.07 5 0.03
G8P[6]+P[8] 0 0.00 0 0.00 2 0.03 2 0.01
G8P[4]+P[8] 0 0.00 0 0.00 1 0.01 1 0.01
G8+G12P[6]+P[8] 0 0.00 0 0.00 2 0.03 2 0.01
G8+G12P[4]+P[6] 0 0.00 0 0.00 1 0.01 1 0.01
G8P-UD 0 0.00 1 0.01 1 0.01 2 0.01
Total G8 6 0.16 9 0.11 95 1.40 110 0.57
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rural populations, whereas G2P[4] (x2=8.07, P<
0.005) and G9P[8] (x2=19.62, P<0.0001) were found
more commonly in urban populations (Table 6b). The
increased incidence of G9P[8] and G2P[4] strains in
the urban population may reﬂect the recent intro-
duction of either an antibody escape mutant, such as
seen previously with G2P[4], or an animal human re-
assortant, such as G9P[8]. The decreased incidence of
G1P[8] in the urban population may be a result of the
increased activity of G2P[4] and G9P[8] resulting in
fewer susceptible individuals.
Distribution according to gender
For those subjects for whom gender was provided,
54.7% were male and 45.3% were female, which re-
ﬂects the European birth cohort male :female ratio of
1.21:1. No signiﬁcant diﬀerences in the distribution of
common or emerging rotavirus strains were found
between males and females (Table 6c).
DISCUSSION
EuroRotaNet, was established in order to determine
the diversity of co-circulating rotavirus strains in
Europe over three or more rotavirus seasons from
2006/2007. Initially, 11 countries participated in the
network and this had expanded to 16 countries by the
2008/2009 season. For analytical purposes, limited
epidemiological data including age, sex, symptoms,
date of onset, date of sample collection, country, re-
gion and settings, including hospital or community
and rural or urban were collected.
The data on seasonality conﬁrm the previously re-
ported trend that rotavirus infections spread in
Europe from South to North andWest to East. This is
similar to that observed in North America [20].
It might be expected that genotypes with a rela-
tively low incidence are at a disadvantage in terms of
transmission opportunities, and this is likely to be
reﬂected by an increase in infections in older children.
Data from Table 7, with the exception of G2P[4], do
not support this, and the rationale for common
strains such as G1P[8] and uncommon strains such as
G8P[4] to signiﬁcantly infect children between ages 14
and 15 months, is unexplained. The signiﬁcant peak
of infection in older children associated with G2P[4]
may reﬂect poor cross-protection generated through
previous infections with other common human rota-
virus strains. Interestingly, this may reﬂect a repli-
cative disadvantage of this strain in a mixture of
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Fig. 3. Changing strain distribution in seasons and countries
between 2006 and 2009. &, 2006/2007; %, 2007/2008; ,
2008/2009.
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predominantly ﬁt viruses infecting an immuno-
logically naive child. This taken with the development
of immunological protection against the commonly
circulating strains at a young age increases the prob-
ability that any new infection in an older child is likely
to be with a less common, possibly less ﬁt strain, such
as G2P[4].
This report highlights the tremendous diversity
of rotavirus strains co-circulating in the European
population and points to the many origins of these
strains including genetic reassortment and inter-
species transmission. Mixed infections and zoonotic
introductions are common, but many will lead to
evolutionary dead-ends with only those virus strains
demonstrating ﬁtness for transmission within the
human population emerging to become signiﬁcant
human pathogens.
The G- or P-types associated with partially typed
strains were representative of those genotypes seen in
fully characterized strains. Therefore, failure to type
is most likely to be associated with technical issues
and/or low viral load, although occasionally they
may represent usual genotypes, particularly in those
associated with an animal rotavirus G- or P- types
[21–26]. The failure to identify G-types associated
with P[6], P[9], P[10], P[11] and P[14] may be associ-
ated with the presence of unusual G-types for which
G genotype-speciﬁc primers were not included in the
study protocol. Similarly, the inability to determine
the P-type of strains with G12 or G10 may be due to
a lack of P genotype-speciﬁc primers. Interestingly,
other strains associated with these G- or P-types were
fully characterized during the study.
With the ability of the network to identify strains
circulating with an incidence of 1%, possible emerg-
ing strains such as G8 and G12 have been identiﬁed
during the ﬁrst 3 years of the study and the analysis of
recent data indicates their increased incidence.
G12P[6] and G12P[14] are likely to represent zoo-
notic spread into the human population, whereas,
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G12P[4] and G12P[8] are more likely to be the result
of reassortment in human and animal strains. The
plethora of mixtures of rotaviruses containing G12
strains may suggest environmental or food-/water-
borne transmission events. Mixtures can also be
seen to contain potential zoonotic strains other than
G12 such as G8, G10, P[6], P[9] and P[11] and so
may represent an environmental reservoir of rota-
virus strains associated with a mixture of potentially
contaminating human and animal faeces. Similarly,
G8P[14] and G8P[6] may be zoonotic, whereas,
G8P[4] and G8P[8] may result from reassortment of
an animal strain carrying G8, with human strains.
Twenty-four mixtures made up of 12 diﬀerent com-
binations of G- and/or P-types were found, suggesting
infection in some instances through contact with a
mixture of human and animal strains.
The genes encoding VP7 of the G8 strains from the
UK were sequenced. The temporal and geographical
distribution and diversity of G8 strains seen before
2009 may suggest multiple zoonotic introductions
[13, 27–33] whereas the similarity of the strains de-
scribed in the current paper is likely to be the result of
sustained person-to-person transmission of a strain
adapted to the human host (Fig. 5). Interestingly,
when G12 strains from UK, Hungary and Bulgaria
were sequenced, detailed phylogenetic analysis in-
dicated multiple, unrelated, introductions and may
represent a series of evolutionary dead-ends associ-
ated with an inability of these strains to sustain
human-to-human transmission (Fig. 6). It is reason-
able to suggest that because of the frequent intro-
ductions of G12 strains into the human population it
may be only a matter of time before a reassortment
event provides a G12 animal/human hybrid strain of
comparable ﬁtness to those current stains circulating
commonly in the human population.
The introduction of universal rotavirus vaccination
in at least two of the participating countries, and
partial vaccine coverage in some others may provide
data on diversity driven by vaccine introduction and
possible strain replacement. Discussions on changes
to the current EuroRotaNet surveillance protocols in
Table 6. Distribution of common and emerging
rotavirus genotypes. The total number of strains
shown refers to the total number of rotavirus strains
in each of the settings/gender groups, and includes
mixed infections and human rotavirus reassortant
strains (not shown in the table breakdown)
(a) Hospitalized and community cases
Genotype Hospital Community
No. % No. %
G1P[8] 5008 48.24 2900 46.27
G2P[4] 1106 10.65 524 8.36
G3P[8] 383 3.69 336 5.36
G4P[8] 1673 16.11 924 14.74
G9P[8] 1228 11.83 801 12.78
G12 with any 137 1.32 77 1.23
G8 with any 66 0.64 42 0.67
Total typed 10 382 6267
(b) Urban and rural settings
Genotype Urban Rural
No. % No. %
G1P[8] 2677 39.13 371 47.44
G2P[4] 976 14.26 82 10.49
G3P[8] 231 3.38 29 3.71
G4P[8] 1258 18.39 168 21.48
G9P[8] 792 11.58 49 6.27
G12 with any 101 1.48 11 1.41
G8 with any 24 0.35 5 0.64
Total typed 6842 782
(c) Males and females
Genotype Male Female
No. % No. %
G1P[8] 4529 47.63 3710 47.17
G2P[4] 953 10.02 809 10.29
G3P[8] 412 4.33 336 4.27
G4P[8] 1473 15.49 1286 16.35
G9P[8] 1142 12.01 933 11.86
G12 with any 95 1.00 107 1.36
G8 with any 56 0.59 44 0.56
Total typed 9508 7865
Table 7. Median age of infection compared with
overall incidence by genotype
Genotype
Median age
of infections
(months) Incidence (%)
G1P[8] 15 48.43
G2P[4] 22 10.07
G3P[8] 15 4.27
G4P[8] 18 15.06
G9P[8] 15 11.56
G8P[4] 14 0.34
G12 with any P 19 1.19
Mixed genotypes 18 4.22
12 M. Iturriza-Go´mara and others
light of rotavirus vaccine introduction will be held
during the course of the next two seasons and will
involve participants, funders and the European
Centre for Diseases Control (ECDC). In light of
these developments, it should now be possible for
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EuroRotaNet, with others, to evolve into a network
capable of performing detailed rotavirus surveillance
activities. These activities would provide data on the
eﬀectiveness of rotavirus vaccination programmes and
the impact of these programmes on the virus popu-
lations co-circulating in Europe, and the changing
patterns of infections by age, season, setting, etc.
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